Global Precision Oncology Market 2026-2030

Description

The global precision oncology market is forecasted to grow by USD 71113.5 mn during 2025-2030, accelerating at a CAGR of 9.5% during the forecast period. The report on the global precision oncology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements in next-generation sequencing and molecular diagnostics, integration of ai and ml in therapeutic decision-making, escalating global cancer prevalence and transition to value-based healthcare models.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2025
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	9.4%
CAGR	9.5%
Incremental Value	$71113.5 mn

Technavio's global precision oncology market is segmented as below:

By Type

Therapeutics
Diagnostics
Companion and monitoring services

By End-User

Hospitals and diagnostic laboratories
Pharmaceutical and biotechnology companies
Academic and research institutes
Healthcare data companies

By Technology

Genomic sequencing and bioinformatics
Biomarker discovery
Molecular imaging
Data analytics and AI

Geography

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Russia
Asia
Rest of World (ROW)
Rest of World (ROW)

This study identifies the proliferation of multi-cancer early detection and liquid biopsy integration as one of the prime reasons driving the global precision oncology market growth during the next few years. Also, acceleration of ai and computational oncology in personalized drug discovery and expansion of precision immunotherapy and targeted delivery systems in emerging markets will lead to sizable demand in the market.

The report on the global precision oncology market covers the following areas:

Global precision oncology market sizing
Global precision oncology market forecast
Global precision oncology market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global precision oncology market vendors that include Agilent Technologies Inc., Bio Rad Laboratories Inc., Caris Life Sciences, Exact Sciences Corp., Foundation Medicine Inc., Guardant Health Inc., Illumina Inc., Laboratory Holdings Inc., Myriad Genetics Inc., Natera Inc., NeoGenomics Laboratories Inc., Pillar Biosciences Inc., Predicine Inc., QIAGEN N.V., Quest Diagnostics Inc., SOPHiA GENETICS, Sysmex Corp., Tempus AI Inc., Thermo Fisher Scientific Inc., Velsera Inc. Also, the global precision oncology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR81598

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
2.3 Factors of disruption
2.4 Impact of drivers and challenges

3 Market Landscape

3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis

4 Market Sizing

4.1 Market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Global Precision Oncology Market 2020 - 2024
- Historic Market Size - Data Table on Global Precision Oncology Market 2020 - 2024 ($ million)
5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
5.4 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global Precision Oncology Market
6.2 Impact of geopolitical conflicts on Global Precision Oncology Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition

8 Market Segmentation by Type

8.1 Market segments
8.2 Comparison by Type
8.3 Therapeutics - Market size and forecast 2025-2030
8.4 Diagnostics - Market size and forecast 2025-2030
8.5 Companion and monitoring services - Market size and forecast 2025-2030
8.6 Market opportunity by Type
- Market opportunity by Type ($ million)

9 Market Segmentation by End-user

9.1 Market segments
9.2 Comparison by End-user
9.3 Hospitals and diagnostic laboratories - Market size and forecast 2025-2030
9.4 Pharmaceutical and biotechnology companies - Market size and forecast 2025-2030
9.5 Academic and research institutes - Market size and forecast 2025-2030
9.6 Healthcare data companies - Market size and forecast 2025-2030
9.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)

10 Market Segmentation by Technology

10.1 Market segments
10.2 Comparison by Technology
10.3 Genomic sequencing and bioinformatics - Market size and forecast 2025-2030
10.4 Biomarker discovery - Market size and forecast 2025-2030
10.5 Molecular imaging - Market size and forecast 2025-2030
10.6 Data analytics and AI - Market size and forecast 2025-2030
10.7 Market opportunity by Technology
- Market opportunity by Technology ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
12.2 Geographic comparison
12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.4.7 Russia - Market size and forecast 2025-2030
12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.5.7 Singapore - Market size and forecast 2025-2030
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Australia - Market size and forecast 2025-2030
- 12.6.5 Turkey - Market size and forecast 2025-2030
- 12.6.6 South Africa - Market size and forecast 2025-2030
12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

13.1 Market drivers
- Technological advancements in next-generation sequencing and molecular diagnostics
- Integration of AI and ML in therapeutic decision-making
- Escalating global cancer prevalence and transition to value-based healthcare models
13.2 Market challenges
- Prohibitive costs of advanced molecular profiling and disparities in reimbursement frameworks
- Data privacy concerns and increasing complexity of genomic information security
- Critical shortage of specialized clinical personnel and bioinformatics expertise
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
- Proliferation of multi-cancer early detection and liquid biopsy integration
- Acceleration of AI and computational oncology in personalized drug discovery
- Expansion of precision immunotherapy and targeted delivery systems in emerging markets

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
15.5 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
15.6 Caris Life Sciences
- Caris Life Sciences - Overview
- Caris Life Sciences - Product / Service
- Caris Life Sciences - Key offerings
- SWOT
15.7 Guardant Health Inc.
- Guardant Health Inc. - Overview
- Guardant Health Inc. - Product / Service
- Guardant Health Inc. - Key offerings
- SWOT
15.8 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
15.9 Laboratory Holdings Inc.
- Laboratory Holdings Inc. - Overview
- Laboratory Holdings Inc. - Business segments
- Laboratory Holdings Inc. - Key offerings
- Laboratory Holdings Inc. - Segment focus
- SWOT
15.10 Myriad Genetics Inc.
- Myriad Genetics Inc. - Overview
- Myriad Genetics Inc. - Product / Service
- Myriad Genetics Inc. - Key offerings
- SWOT
15.11 Natera Inc.
- Natera Inc. - Overview
- Natera Inc. - Business segments
- Natera Inc. - Key offerings
- Natera Inc. - Segment focus
- SWOT
15.12 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
15.13 Quest Diagnostics Inc.
- Quest Diagnostics Inc. - Overview
- Quest Diagnostics Inc. - Business segments
- Quest Diagnostics Inc. - Key offerings
- Quest Diagnostics Inc. - Segment focus
- SWOT
15.14 SOPHiA GENETICS
- SOPHiA GENETICS - Overview
- SOPHiA GENETICS - Product / Service
- SOPHiA GENETICS - Key offerings
- SWOT
15.15 Sysmex Corp.
- Sysmex Corp. - Overview
- Sysmex Corp. - Business segments
- Sysmex Corp. - Key news
- Sysmex Corp. - Key offerings
- Sysmex Corp. - Segment focus
- SWOT
15.16 Tempus AI Inc.
- Tempus AI Inc. - Overview
- Tempus AI Inc. - Product / Service
- Tempus AI Inc. - Key offerings
- SWOT
15.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
15.18 Velsera Inc
- Velsera Inc - Overview
- Velsera Inc - Product / Service
- Velsera Inc - Key offerings
- SWOT

16 Appendix

16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations